New! Sign up for our free email newsletter.
Reference Terms
from Wikipedia, the free encyclopedia

COX-2 inhibitor

COX-2 selective inhibitor is a form of Non-steroidal anti-inflammatory drug (NSAID) that directly targets COX-2, an enzyme responsible for inflammation and pain. Selectivity for COX-2 reduces the risk of peptic ulceration, and is the main feature of celecoxib, rofecoxib and other members of this drug class. Cox-2-selectivity does not seem to affect other side-effects of NSAIDs (most notably an increased risk of renal failure), and some results have aroused the suspicion that there might be an increase in the risk for heart attack, thrombosis and stroke by a relative increase in thromboxane. Rofecoxib was taken off the market in 2004 because of these concerns.

Related Stories
 


Health & Medicine News

June 9, 2025

A breakthrough study from Keck Medicine of USC may have found a powerful new triple therapy for glioblastoma, one of the deadliest brain cancers. By combining Tumor Treating Fields (TTFields), which ...
Teens are diving into intense skincare routines inspired by TikTok, often slathering on six or more products daily, sometimes over ten in just minutes, chasing beauty ideals that favor lighter, flawless skin. But new research warns this digital ...
A new Rutgers Health study reveals a surprising twist in the antibiotic resistance story: instead of simply killing bacteria, drugs like ciprofloxacin can actually trigger a kind of microbial survival mode. By crashing the bacteria's energy levels, ...
A rare genetic disorder called Werner syndrome causes premature aging and devastating health complications from an early age, yet treatment options have been lacking. New hope emerges from Chiba University, where researchers conducted the first ...
A revolutionary STI test developed by UK-based Linear Diagnostics is on track to dramatically reduce the time it takes to detect infections like gonorrhea and chlamydia. Built on ultra-fast EXPAR DNA amplification technology, the platform can ...
Genetic research in Sweden has unveiled three new gene variants that dramatically increase the risk of venous blood clots, sometimes by up to 180%. These discoveries build on existing knowledge of Factor V Leiden and suggest that genetics plays a ...
Cannabis use among older Americans has climbed dramatically, with 7% of adults 65 and older now reporting recent use. This rise isn't just in numbers but also in diversity older users today are more likely to be women, college-educated, and ...
A powerful new discovery reveals that Nup98 a protein once thought to only ferry molecules through the nucleus plays a vital role in safeguarding the most vulnerable areas of DNA. By forming droplet-like 'bubbles' around damaged DNA within dense ...
New research reveals a surprising downside to calorie-cutting diets: a link to higher levels of depressive symptoms, especially in men and those who are overweight. Despite popular beliefs that healthy eating boosts mental wellness, real-life ...
A diabetes drug may soon double as a treatment for liver disease. Dapagliflozin, an SGLT-2 inhibitor typically used for type 2 diabetes, significantly improved liver inflammation and scarring in patients with metabolic dysfunction-associated ...
A new type of mRNA vaccine is more scalable and adaptable to continuously evolving viruses such as SARS-CoV-2 and H5N1, according to a new ...
Using a newly devised, three-dimensional model to study the regeneration of nerve tissue in the nose, researchers have discovered that one type of stem cell thought to be dormant may play a more significant role in preserving the sense of smell than ...

Latest Headlines

updated 12:56 pm ET